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Abstract
Advanced free energy perturbation molecular dynamics (FEP/MD) simulation methods are
available to accurately calculate absolute binding free energies of protein-ligand complexes.
However, these methods rely on several sophisticated command scripts implementing various
biasing energy restraints to enhance the convergence of the FEP/MD calculations, which must all
be handled properly to yield correct results. Here, we present a user-friendly web interface,
CHARMM-GUI Ligand Binder (http://www.charmm-gui.org/input/gbinding), to provide
standardized CHARMM input files for calculations of absolute binding free energies using the
FEP/MD simulations. A number of features are implemented to conveniently setup the FEP/MD
simulations in highly customizable manners, thereby permitting an accelerated throughput of this
important class of computations while decreasing the possibility of human errors. The interface
and a series of input files generated by the interface are tested with illustrative calculations of
absolute binding free energies of three non-polar aromatic ligands to the L99A mutant of T4
lysozyme and three FK506-related ligands to FKBP12. Statistical errors within individual
calculations are found to be small (~1 kcal/mol), and the calculated binding free energies generally
agree well with the experimental measurements and the previous computational studies (within ~2
kcal/mol). CHARMM-GUI Ligand Binder provides a convenient and reliable way to setup the
ligand binding free energy calculations and can be applicable to pharmaceutically important
protein-ligand systems.
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Molecular recognition of small molecules by specific receptor proteins is one of the most
important biological processes. Binding of a small molecule to a target protein is required to
change the receptor’s dynamics and/or conformations allosterically, or to interfere with the
protein-protein interactions, aiming at controlling the protein’s functions. Specific protein-
ligand interactions can also be modulated by other small molecules that have similar
physicochemical properties, begging for a quantitative assessment of binding specificity at
the molecular level. For this reason, there is great interest in the concept of rational drug
design based on atomic structures of receptor proteins or receptor-ligand complexes
(reviewed in 1–3).
Arguably, accurate binding free energy calculations could be used to help develop novel
drug molecules and improve the potency of existing ones. Considerable efforts have been
made to reliably calculate the receptor-ligand association free energy at the atomic level
using various computational methods, such as: linear interaction energy (LIE)4; molecular
mechanics with Poisson-Boltzmann or generalized Born/surface area (MM-PBSA/
GBSA)5, 6; or alchemical free energy calculation (reviewed in 7–9). LIE utilizes the energies
calculated from atomic simulations, such as molecular dynamics (MD) or Monte Carlo
(MC) simulations, to estimate the relative free energy difference upon changes in van der
Waals (vdW) and/or electrostatic contributions from the reference. MM-PBSA/GBSA
utilizes the trajectories from MD simulations to capture the dynamical aspect of protein-
ligand interactions, but the produced results are sometimes not predictive.10
Alchemical free energy calculations, particularly, free energy perturbation molecular
dynamics (FEP/MD) simulations, represent the most rigorous computational approach to
calculate receptor-ligand binding free energy. FEP/MD simulations have shown to
accurately calculate the binding affinities in various biologically important systems.11–14
The effect from explicit solvent molecules and flexibility of the molecules can be
incorporated into the calculation, which is shown to be important in macromolecule-ligand
association.15 To improve the robustness and computational efficiency of FEP/MD
simulations, Roux and co-workers have developed a staged FEP/MD simulation protocol
based on a step-by-step decomposition of the total reversible work through various
computational techniques.12, 14 First, the absolute binding free energy is decomposed into
several intermediate steps in which the ligand-surrounding environment interactions as well
as the orientational, translational, and conformational sampling of the ligand are gradually
turned “on” (or “off” depending on the setup). The staged protocol effectively and
rigorously breaks down the complete free energy calculation into several independent MD
simulations, which can be easily distributed over independent computer nodes. Second, the
ligand conformational sampling is explicitly taken into account by umbrella sampling of
ligand conformations based on root-mean-squared deviation (RMSD) from the bound state
of the ligand. Third, Lennard-Jones (LJ) interactions between the ligand and the surrounding
environment are decomposed into repulsive and dispersive interactions using the Weeks-
Chandler-Andersen (WCA) separation, which improves the convergence of the calculation.
Fourth, to reduce the computational cost and complexity, only a small region of interest near
the receptor-ligand binding site is explicitly considered using solvent boundary potential
methods.16, 17
The performance of the staged FEP/MD simulation method has been already tested with
various biologically important systems and demonstrated that binding free energy can be
calculated accurately with errors less than 2 kcal/mol (compared to experimental
values).12, 14, 18 However, the setup of the staged FEP/MD simulation protocol is not trivial
even for expert researchers due to the many restraint potentials and large number of
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intermediate windows. In addition, selection of a set of anchoring atoms for orientational/
translational restraint potentials could be arbitrary and requires prior knowledge of the
ligand system.
In this work, we have generalized the staged FEP/MD simulation protocol12, 14 and
implemented CHARMM-GUI Ligand Binder (http://www.charmm-gui.org/input/gbinding),
a web interface that provides standardized input files for calculations of absolute binding
free energies. In addition, Ligand Binder has a number of features that can help users to
setup the FEP/MD simulations with less human intervention. For example, automatic ligand
force field generation, symmetric group detection, system size estimation, and anchoring
atom selection/validation are implemented to quickly generate reliable FEP/MD simulation
systems and inputs. To test the efficacy of the interface, we have calculated absolute binding
free energies of three non-polar small aromatic ligands to the L99A mutant of T4 lysozyme
and three FK506-related ligands to FKBP12. The calculated binding free energies generally
agree well with the experimental measurements and the previous computational studies.
Therefore, Ligand Binder provides a convenient and reliable way to setup the ligand binding




The theoretical framework for calculation of absolute binding free energy used in this work
is well formulated in the previous studies12, 14 and is closely related to the double
decoupling method.19, 20 According to this framework, a step-by-step FEP/MD simulation
protocol with restraining potentials is carried out to break down the complete alchemical
reaction path into a number of intermediate physical states (FEP windows). The ordered
step-by-step FEP/MD can be briefly summarized as: (1) switch-on the RMSD restraint
potential on the ligand conformation in the binding site, (2) switch-on the relative ligand-
receptor positional/rotational restraint potentials (in the presence of the RMSD restraint), (3)
switch-off the ligand interactions with the binding site environment (in the presence of the
RMSD and positional/rotational restraints), (4) switch-off the positional/orientational
restraint potentials (this contribution is evaluated analytically), (5) switch-on the ligand
interactions with the bulk solution environment (in the presence of the RMSD restraint), (6)
switch-off the conformational RMSD restraint potential on the ligand in bulk solution. The
various restraining potentials introduced in the successive FEP windows are used to
maintain the position and orientation of the ligand around the “pose” adopted in the bound
complex. These restraining potentials help enhance configurational sampling and also serve
to correctly handle the decoupled ligand states. In the following sections, we will focus on
its generalization and implementation in CHARMM-GUI Ligand Binder.
General FEP/MD setup using CHARMM-GUI Ligand Binder
The CHARMM input files generated by Ligand Binder are arranged in six distinct steps for
clarity and convenience (Table 1). Ligand Binder produces both inputs and outputs for
STEP 1 and STEP 2 for a given protein-ligand complex, but only generates the inputs files
of the remaining equilibration and production steps of the FEP/MD simulations because they
generally require extensive computational resources. In this section, the role of each step and
the corresponding outcomes are discussed in detail. As shown in Table 1, for easy
recognition the generated input files have a corresponding step number in their filename
followed by the two different tags, “BULK” and “SITE”, to represent the FEP/MD
simulation systems in bulk solvent and in the protein binding site, respectively. Hereinafter,
for brevity, the simulation systems with protein/ligand complex and the ligand molecule in
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the bulk solvent are referred to as SITE and BULK, respectively. Various accessory scripts
that are compatible with UNIX and portable batch system (PBS) are also provided to
perform actual FEP/MD simulations conveniently.
STEP 1: Reading of a protein-ligand complex into CHARMM—In this step, the
web interface generates inputs to read a protein-ligand complex into the molecular dynamics
simulation program CHARMM.21 A user can upload a PDB format file or provide a PDB
entry ID from the RCSB protein databank22 that contains the protein-ligand complex.
Because a molecular force field (FF) is not generally available for many small molecules,
the web interface provides several options: (1) if the small molecule’s topology and
parameter is already included in the CHARMM standard FF, a user simply needs to leave
the residue name as it is or rename it to match the residue name in the CHARMM FF; (2) if
a user already has a CHARMM FF customized for the user’s small molecule, the topology
and parameter files can be uploaded and used; (3) if no FF is available, Ligand Binder
provides an option for automated FF generation based on the CHARMM general FF
(CGenFF)23 or general AMBER force field (GAFF)24, 25 to generate the ligand CHARMM
FF (see below for details). Symmetric groups (currently, planar ring or t-butyl-groups) are
algorithmically recognized after the topology generation and used in the later steps to apply
flat-bottom dihedral restraints for preventing exchanges between physically identical
rotameric states. Simple protein structure modifications (e.g., disulfide bond generation,
terminal group changes, phosphorylation, and protonation) can also be made during this step
(see ref. 26 for details).
STEP 2: Solvation of the systems—Once a protein-ligand structure is successfully
initialized in CHARMM, the protein-ligand system is solvated in a water box. The current
interface supports a spherical water box for a reduced system with solvent boundary
potentials and an orthorhombic water box for the full system with periodic boundary
conditions (PBC). While one can generate the FEP/MD simulation inputs for the full system
with PBC, only the reduced system is used for the illustrative purposes in this work. The
size of the spherical water box (Rwat) from the ligand’s center of mass (COM) can be
specified by a user-defined value. For the user’s convenience in determining the size, the
extent of the ligand (Rlig) is provided on the interface. Based on our experience and
extensive testing, Rwat that is at least (Rlig + 1Å) for BULK and (Rlig + 5Å) for SITE are
recommended for stable simulations. Nonetheless, Rwat may need to be optimized for
specific problems. If a ligand molecule is composed of a small number of atoms, it may not
be necessary to calculate the conformational free energy change upon binding. Therefore,
the option for the conformational free energy simulation is unchecked by default if Rlig is
smaller than 5 Å, but it can be turned on by the user.
With the given option in this step, Ligand Binder generates the input and output files for
STEP 2, as well as the input files for the rest of the FEP/MD simulations (STEP 3–6). The
user can download the generated files in an archived file and carry out the FEP/MD
simulations on user’s machine. It should be noted that although many parts of the input files
are similar for different ligands, some system-dependent parameters are inserted during the
input generation. Thus, it is advised to re-generate the input files through Ligand Binder
instead of copying and modifying the input files for different ligands if the user is not
confident.
STEP 3: Setup of the solvent boundary systems—In this step, the solvent boundary
potentials are set up to generate the reduced atomic systems. For SITE, the generalized
solvent boundary potential (GSBP)17 is used. Ligand Binder uses the following setup for the
GSBP system as a default. A spherical inner region is defined by Rwat from the ligand’s
COM. All the atoms within the inner region are allowed to move during the equilibration
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and FEP/MD simulations. The inner region is extended by 3 Å to define a smooth spherical
dielectric cavity (Rsphere). The protein atoms in the extended region (Rwat < R < Rsphere) as
well as the atoms in the inner region linked via 1–3 bonds with the protein atoms in the outer
region (> Rsphere) are fixed according to a group-based criterion. The water molecules in the
outer region are removed and treated implicitly, and the inner region water molecules that
overlap with the ligand and the protein are also deleted. The long-range electrostatic
influence of the protein atoms in the outer region on the atoms in the inner region is
represented in terms of the solvent-shielded static field and the solvent-induced reaction
field. The reaction field due to the variations of the charge distribution in the inner region is
expressed in terms of a generalized multipolar expansion using 11 spherical harmonic
functions by default. The solvent-shielded static field and the reaction field matrix are
calculated by the finite-difference Poisson-Boltzmann (PB) method using the PBEQ
module27 in CHARMM, assuming a dielectric constant of 1 inside the protein as well as the
inner and extended regions, and 80 otherwise. A non-polar cavity potential is used to keep
the water molecules inside the inner region.
For BULK, the spherical solvent boundary potential (SSBP)16 is used together with the
spherical water box generated in the previous step. The water box and the ligand molecules
are centered at the origin, and water molecules that overlap with the ligand are deleted.
STEP 4: Equilibration of the systems
Equilibration of SITE (steps 4.1 and 4.2): To overcome the problem that the size of the
inner system is invariant during the subsequent simulations, the grand canonical Monte
Carlo (GCMC) method is used to hydrate the inner region properly (step 4.1).28 In this step,
20 cycles of MC and MD simulations are performed. Each cycle is comprised of 10,000 MC
moves followed by 10,000 MD steps with a time-step of 2 fs. The MC steps include rigid
body translation, rotation, and GCMC insertion/deletion of water molecules, and each move
type has the equal probability. A harmonic restraint potential with a force constant of 5.0
kcal/(mol·Å2) is applied to the protein and the ligand molecule throughout the MD
simulations. All bonds involving hydrogen atoms are fixed with the SHAKE algorithm.29
The simulation is carried out using Langevin dynamics at 300 K with a friction coefficient
of 5 ps−1 assigned to all non-hydrogen atoms. During the simulation, nonbonded interactions
within 14.5 Å are explicitly accounted and the rest is treated with an extended electrostatics
method. After 20 cycles of GCMC/MD simulations, the protein-ligand complex is
equilibrated (step 4.2) for 200 ps at 300 K using Langevin dynamics with the same option as
in step 4.1, but without the positional harmonic restraint.
Geometric and conformational restraint setup (step 4.3): In this step, a set of anchoring
atoms for the translational and orientational restraints are determined and the detailed
procedures are described below. After the anchoring atoms are determined, the last 190-ps
equilibration trajectory is used to calculate the average reference distances, angles, and
dihedrals for the translational/orientational restraints. If the ligand has a symmetric group,
the average dihedral angle around the symmetric group is also calculated. The average
ligand conformation during the equilibration simulation is first calculated followed by a
short energy minimization. The resulting averaged and minimized ligand structure is used as
the reference configuration for the conformational restraint during FEP/MD simulations.
Equilibration of BULK (step 4.4): The ligand molecule in bulk solvent is equilibrated for
200 ps at 300 K using the SSBP method and Langevin dynamics with the same option as in
step 4.1. A weak positional restraint potential with a force constant of 0.5 kcal/(mol·Å2) is
applied to the ligand’s COM to prevent the ligand from drifting away from the origin. The
conformational restraint potential using the averaged ligand structure calculated in step 4.3
Jo et al. Page 5













is applied to keep the reference conformation during the equilibration if the conformational
free energy calculation option is selected in STEP 2.
STEP 5: FEP/MD and RMSD-umbrella sampling simulations—In this step, the
FEP/MD simulations are carried out to calculate free energies associated with restriction of
ligand conformation to the reference conformation (ΔGc), restriction of ligand orientation
and translation (ΔGt,r), and interactions with surrounding environments (ΔGint). In the
current scheme, the FEP/MD simulations are divided into a total of 137 independent (FEP/
RMSD window) simulations that can be distributed over independent computer nodes.
During the simulations, the perturbation energies for each state are collected for the later
analysis. All simulations are carried out using Langevin dynamics with the same option as in
step 4.1. An accessory script (step5_jobmanager.com) is provided to automatically check
finished jobs and to (re)submit the FEP/MD and RMSD-umbrella sampling simulations (see
Table 1). If necessary, optional GCMC simulation can be performed to adjust the solvation
of reduced system during the FEP/MD simulations (the GCMC simulation option has to be
turned on in the STEP 2).
Conformational free energy: To calculate the free energy associated with the restriction of
the ligand conformation in the bound state, the conformational free energies (  and
) are estimated by calculating the potential of mean force (PMF) as a function of
ligand RMSD using umbrella sampling simulations.30 Simulations are carried out using the
quadratic biasing potential, kc(ξ − ξi)2, where kc is the force constant, ξ is the instantaneous
RMSD with respect to the average ligand conformation in the bound state that is calculated
from the SITE equilibration, and ξi is the RMSD offset value of each window. A total of 21
biasing windows are used with the RMSD offset value from 0.0 to 5.0 Å in steps of 0.25 Å
for the ligand in SITE and BULK. The initial configurations for the 21 umbrella sampling
windows are generated using a short initial run (20 ps) with a strong force constant of 500
kcal/(mol·Å2). Then, each window is simulated using a force constant of 10 kcal/(mol·Å2)
for 110 ps and the data from the last 100-ps simulations are collected, which corresponds to
one cycle.
During the umbrella sampling simulation for SITE, dissociation of the ligand from the
binding pocket may occur for some windows with a large RMSD offset value due to large
distortion of the ligand conformation. According to the strict step-by-step free energy
decomposition scheme adopted in the present work, the translational degrees of freedom of
the ligand should not be restricted at this stage. Nevertheless, to avoid the spurious
contributions to the PMF from an unbound ligand, a flat-bottomed translational restraint
with a small force constant (1.0 kcal/(mol·Å2)) is applied. This restraint, which allows free
diffusion of the ligand’s COM within a spherical region of 2 Å radius centered around the
initial position of ligand’s COM, is sufficient to prevent the ligand from leaving the binding
pocket.
If symmetric groups (e.g., planar ring group or t-butyl group) are present in the ligand,
interconversion between the physically equivalent conformations will make the ligand
conformational sampling more challenging. Insufficient sampling will eventually lead to an
inaccurate estimation of loss of conformational freedom upon ligand binding. To avoid this
problem, a steep flat-bottom dihedral restraint potential with a force constant of 500 kcal/
(mol·rad2) is applied to each of the symmetric unit of the ligand during all the calculations in
BULK and SITE.
Translational and rotational free energy: The free energies corresponding to restriction of
the ligand’s translational and rotational degrees of freedom near the binding site ( ) are
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calculated using FEP/MD simulations. The six point positions in the protein (P1, P2, and P3)
and the ligand (L1, L2, and L3) determined in step 4.3 (see below for details) are used to
define the relative position and orientation of the ligand with respect to the protein. A total
of three translational (1 distance, 1 angle, and 1 dihedral restraints) and three rotational
restraints (1 angle, 2 dihedral restraints) are applied with the reference values determined in
step 4.3. The translational and rotational restraints are gradually turned on via the linear
coupling parameters λt,r (Table 2) to final force constants of 10 kcal/(mol·Å2), 200 kcal/
(mol·rad2), and 200 kcal/(mol·rad2) for the distance, angle, and dihedral restraints,
respectively. For each set of coupling parameters, 50-ps simulations are performed and the
data from the last 40-ps simulations are collected, which corresponds to one cycle.
Interactions with surrounding environments: The contributions from the interactions of
the ligand with its surrounding environments (  and ) are calculated with FEP/
MD simulations. The Lennard-Jones (LJ) potential is separated into repulsive and dispersive
free energies using the WCA separation method.31 Associated coupling parameters, λrep,
λdisp, and λelec are introduced to control the repulsive, dispersive, and electrostatic
interactions, respectively (Table 2). For each set of coupling parameters, 110-ps simulations
are performed and the data from the last 100-ps simulations are collected, which
corresponds to one cycle.
STEP 6: Calculation of the binding free energy—In the current staged FEP/MD
simulation scheme, the final binding free energy can be expressed as
(1)
where  represents the free energy change due to non-bonded
interactions between the ligand and its environment.  and
 represent the free energy changes due to the loss of
conformational freedom and the translational/rotational freedom, respectively. The ligand’s
translational (Ft) and rotational (Fr) freedoms in BULK are calculated analytically.12,14
In this step, the data generated in STEP 5 are aggregated and each term in the standard
binding free energy is computed. The weighted histogram analysis method (WHAM)32, 33 is
used to evaluate the PMF as a function of RMSD from the umbrella sampling simulations in
STEP 5; a Fortran WHAM code is provided. The free energy change due to the loss of
conformational freedom (ΔGc) is calculated by integration of the Boltzmann factor of the
RMSD PMF. For BULK,  is given by
(2)
where  is the ligand PMF as a function of its RMSD with respect to the reference
ligand conformation (i.e., average structure calculated in step 4.3). A similar expression is
used for .
The data from the STEP 5 FEP/MD simulations (for  and ) are unbiased using
the WHAM facility in CHARMM. The individual free energy components are calculated for
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the ligand in SITE and BULK, respectively. Once individual free energy components are
computed, a table of free energy can be printed using an accessory script (step6_table.py).
Automatic Generation of Ligand Force Field
Ligand Binder provides automatic FF generation options for small molecules using
CGenFF23 or GAFF.24, 25 The initial structure of a ligand molecule with proper protonation
states and explicit hydrogen atoms is required. When the CGenFF option is selected, Ligand
Binder communicates with the ParamChem server (http://www.paramchem.org), which
automatically generates the ligand FF based on analogy to known small molecular FF
parameters. The ParamChem server assigns the charge and parameter penalty values, which
could be used as indicative values for the parameter quality, and it is advisable to check if
further optimization is needed before performing the FEP/MD simulations. Although it is
not generally recommended due to a compatibility issue, a ligand FF based on GAFF can be
generated. When the GAFF option is selected, the topology and parameters of the ligand are
generated in the CHARMM format using the Antechamber toolkit.25 The charges of the
ligands are from AM1/BCC,34 and an explicit charge state can be specified in the case that
the ligand molecule is not neutral.
Automatic Determination of Anchoring Atoms
The translational and orientational restraint potentials applied to the ligand in the binding
site are constructed from six anchoring atoms: three point positions in the protein (P1, P2,
and P3) and three point positions in the ligand (L1, L2, and L3) (Figure 1). Ligand Binder
provides a protocol for the automatic selection of reasonable anchoring points for any
protein-ligand complex in step 4.3. Although it is referred to as an anchoring “atom”, the
average coordinates of a group of atoms are used to define each anchoring position.
Specifically, L1 is defined by the COM of a non-hydrogen ligand atom (L0) closest to the
ligand’s COM and the ligand atoms that are bonded to L0. P1 is defined by the receptor
backbone heavy atoms of a residue that is closest to the receptor’s COM. If the distance
between P1 and L1 is too close (< 5Å) or too far (> 10 Å), P1 is randomly reselected from
the receptor backbone heavy atoms of a residue within a distance of 5 – 10 Å from L1. P2 is
defined by the receptor backbone heavy atoms of a residue that satisfy the condition of 60° ≤
∠L1P1P2 ≤ 120°. P3 is defined by the receptor backbone heavy atoms of a residue that
satisfy the condition of 60° ≤ ∠P1P2P3 ≤ 120°. L2 (and L3) is defined by the COM of a
ligand heavy atom and the atoms bonded to the heavy atom with the following conditions;
30° ≤ ∠P1L1L2 ≤ 150° and 30° ≤ ∠L1L2L3 ≤ 150°. These conditions were empirically
established through extensive testing to ensure consistent FEP/MD results.
The translational restraint is defined as Ut = 1/2[kt(r − r0)2 + ka(θ − θ0)2 + kd(φ − φ0)2],
where r is the distance between P1 and L1, θ is the angle ∠P2P1L1, and φ is the dihedral
angle ∠P3P2P1L1. kt, ka, and kd are the force constants for distance, angle, and dihedral
angle restraints, respectively, and r0, θ0, and φ0 are the reference restraint values taken from
the equilibration simulation in SITE (step 4.3). Similarly, the orientational restraint is
defined as , where α is the angle ∠P1L1L2, β is the
dihedral angle ∠P2P1L1L2, and γ is the dihedral angle ∠P1L1L2L3. In principle, the six
anchoring atoms could be chosen arbitrarily without affecting the outcome of the FEP/MD
calculations. However, poorly chosen anchoring atoms may yield geometric restraints that
are ineffective to maintain the relative ligand-receptor orientation and cause undesired
instabilities during the FEP/MD simulations. For this reason, it is important to select an
adequate set of anchoring atoms.
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In order to test a series of input files generated by Ligand Binder, illustrative calculations of
absolute binding free energies were preformed for three non-polar aromatic ligands to the
L99A mutant of T4 lysozyme and three FK506-related ligands to FKBP12 (see Figure 2 for
the ligand structures) in the reduced simulation systems (Figure 3 and Table 3). The protein-
ligand complex structures from the PDB in Table 3 were used to initialize the structures in
Ligand Binder. The FF for each ligand was automatically generated by CGenFF with ligand
structure files obtained from the PDB without modification. As mentioned above, the
ParamChem server annotates the charge and parameter penalties as an indicative value for
the parameter quality. The three nonpolar ligands used in T4 lysozyme L99A mutant had
zero penalties for charge and parameter values. The three FK506-related ligands had a
charge penalty of about 100 and a parameter penalty of about 141. Although further
optimizations for the entries with a penalty greater than 50 are recommended by the authors
of the ParamChem server, such an optimization was not attempted in this work.
All the MD simulations were carried out using CHARMM.21 All the simulation system
setup and FEP/MD calculations were performed using the input files generated by Ligand
Binder without further modification. For the non-polar ligands in T4 lysozyme L99A
mutant, the option for the conformational free energy calculation was not selected due to
their small sizes by default. Figure 3 shows a typical reduced protein/ligand complex system
for SITE and BULK using GSBP17 and SSBP16 boundary potentials. The number of water
molecules is given in Table 3 before and after the hydration of SITE using GCMC/MD
simulations. Each protein/ligand complex system was equilibrated for 200 ps with Langevin
dynamics without any biasing restraints. After equilibration was done for SITE, the
anchoring atoms for the translational and orientational restraints were automatically chosen
and stored in a stream file (step4.3_restraint_geo.prm) for the FEP/MD simulations. The
equilibration trajectory was also used to determine the reference values for the distance (r),
angle (θ and α), and dihedral (φ, β, and γ) restraints (Figure 1). The list of anchoring atoms
used in the simulation as well as the reference values are given in Supporting Information
Table S1. The BULK systems were also equilibrated for 200 ps with Langevin dynamics
with ligand conformation restrained using the average ligand conformation from the SITE
equilibration as a reference.
For each protein-ligand complex in Table 3, 10 cycles of FEP/MD simulations were carried
out for better convergence. The conformational free energy term was not calculated for T4
lysozyme ligands due to small ligand size. Each cycle consisted of 10-ps equilibration and
100-ps production except for the translational/rotational free energy contribution (10-ps
equilibration and 50-ps production). Each cycle was started using the last coordinates of the
previous cycle with random initial velocities. The free energy values and the errors are
presented using the average and the standard deviation of the last five cycles, respectively.
Two additional (independent) 10-cycle FEP/MD simulations were performed using different
sets of automatically chosen anchoring atoms to illustrate the robustness of our scheme for
anchoring atom selections.
RESULTS AND DISCUSSION
To examine and illustrate the FEP/MD simulation protocol adopted in CHARMM-GUI
Ligand Binder, the 18 test FEP/MD simulations using six different protein-ligand complexes
were performed (Table 3). The calculated standard binding free energies are given in Table
4. In this section, we first discuss the FEP/MD calculation results, and a general discussion
on the binding free energy calculation results is then followed.
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Illustration of FEP/MD simulations using CHARMM-GUI Ligand Binder
For each ligand, the reduced systems were copied to make three independent simulation
systems. The GCMC/MD simulations and the equilibrations were performed independently.
In addition, different sets of anchoring atoms were used for each independent simulation. By
doing so, the independent simulations serve to estimate the impact of slightly different initial
conditions and different selections of anchoring atoms on the final binding free energies
(C1, C2, and C3 in Table 4).
The reduced GSBP representation of the binding site is hydrated with GCMC/MD
simulations in the presence of the ligand molecule during the equilibration step 4.1, and the
number of water molecules was fixed during the FEP/MD simulations. Although Ligand
Binder provides an option to allow the number of water molecules to fluctuate during the
FEP/MD simulations, such option was not activated in this study to reduce the
computational time. Based on additional tests, the final binding free energies of the test
systems in the current study are not significantly affected by allowing the number of water
to fluctuate during the FEP/MD simulations, which is in agreement with the observation
recently made by Lee et. al.35 However, rehydration of the binding site could be potentially
important to accurately calculate the binding free energy when the size of the reduced
system is small or the size of the ligand is large.28
In general, the smaller size of T4 lysozyme non-polar ligands had more consistent results for
each independent calculation with better convergence compared to larger FKBP ligands.
Better convergence of smaller non-polar ligands is expected due to the small size of the
ligand and well-defined hydrophobic binding pocket in the receptor. In contrast, FKBP
ligands showed relatively larger standard deviations (1–2 kcal/mol) between the cycles of
FEP/MD simulations. In addition, the calculated binding free energy of an independent
system showed about 1–2 kcal/mol differences.
When compared to the previous computational results12, 14 and experimental data36, 37 in
Table 5, our results generally agree well within statistical errors, although there are
differences for specific systems. For example, the calculated binding free energy of indole is
about 2 kcal/mol less favorable than the previous calculation,12 and the calculated free
energy of FKBP ligands in this work showed more statistical errors compared to the
previous calculations.14 Although the current protocol implemented in Ligand Binder is
based on the previous work done by Roux and co-workers,12, 14 there are several reasons for
such discrepancy. Certainly, longer equilibration and careful adjustments of ligand FF
parameters could enhance the accuracy of the calculation results. For instance, a different FF
parameter set was used (CHARMM PARAM2238 FF in ref 12 and Antechamber toolkit25 in
ref 14) and/or the sampling time was much longer in the previous calculations (about 1–2 ns
in ref 14 versus about 100 ps in this work for each cycle). Because the purpose of the current
work is to illustrate the standardized and automated protocol for absolute binding free
energy calculations, further optimization is not performed. Certainly, some optimization by
user (e.g., force field parameters and equilibration/sampling times) could be beneficial.
Validation of anchoring atoms for orientational restraints
In the current FEP/MD simulation protocol, the restraint potentials are used to maintain the
position and orientation of the ligand around the “pose” adopted in the bound complex.
These restraints are also used to calculate the contributions from the restriction of
orientational and translational degrees of freedom of the ligand molecule upon its binding to
a receptor protein. A set of six anchoring atoms (three from the receptor protein and three
from the ligand molecule) is selected to define the ligand position and orientation in terms of
distance, angle, and dihedral angles (Figure 1).
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In principle, the final binding free energy should not be affected by the choice of anchoring
atoms. The translational and orientational restraints have been widely adopted in the double
decoupling method12, 13, 20, 39 and the choice of anchoring atoms were shown to have only
minimal influences on the final binding free energy.20 However, it is easy to imagine
possible sets of anchoring atoms that are problematic. For example, if a set of anchoring
atoms in the ligand yields a co-linear reference angle (e.g., ∠L1L2L3 ~ 180°), the orientation
of the ligand relative to the receptor will be poorly defined. Poor choices can be avoided
when the anchoring atoms are selected manually, but objective criteria must be implemented
when the anchoring atoms are selected by an automated protocol. Ligand Binder provides an
automated anchoring atom selection protocol, which carries out some basic tests to prevent a
poor choice of anchoring atoms.
Table 6 shows the sum of  and ΔΔGt,r from independent FEP/MD simulations with
different sets of anchoring atoms. Because the orientational and translational restraint
potentials were applied during the FEP/MD simulations of  and ΔΔGt,r, the individual
free energy terms calculated using different sets of anchoring atoms could have different
values, but the sum of these terms should remain unchanged regardless of the choice of the
anchoring atoms. As shown in the sum of  and ΔΔGt,r from the independent FEP/MD
simulations, different sets of anchoring atoms automatically chosen by Ligand Binder have
only minimal impacts on the final free energy, illustrating that the automatic anchoring atom
selection in Ligand Binder is reliable.
CONCLUSIONS
In this work, we have developed a web interface, CHARMM-GUI Ligand Binder (http://
www.charmm-gui.org/input/gbinding), to provide standardized CHARMM input files for
absolute binding free energy calculations using the FEP/MD simulations. The sophisticated
staged FEP/MD simulation protocol based on the step-by-step decomposition of the total
reversible work representing the binding process12, 14 is adopted in Ligand Binder. The
method is closely related to the double decoupling method,19, 20 and it has been applied to
calculate absolute binding free energies in a number of biologically important systems.11–14
Ligand Binder has a number of features that help the user to setup the FEP/MD simulations
in straightforward manners. First, a ligand FF can be easily generated and incorporated into
the simulation inputs. Although a careful parameterization may need to be carried out by the
user for improved results, a ligand FF can be generated automatically using either CGenFF23
or GAFF.24, 25 In addition, Ligand Binder can automatically detect symmetric groups based
on the ligand topology (e.g., currently planar ring and t-butyl group) and generate all the
necessary input files. Another important feature of Ligand Binder is to provide a robust
method to select anchoring atoms without knowing the ligand molecule a priori. All input
files generated by Ligand Binder can be downloaded, which allows customization of the
FEP/MD simulation protocol if necessary.
The current implementation of Ligand Binder supports reduced system representation using
SSBP for the ligand in solution, and GSBP for the protein binding site. While these
approaches provide useful approximations, it is important to note the situations for which
there can be problems. Usage of GSBP, in particular, could result in systematic deviations
and inaccuracies of the calculated binding free energies when the receptor protein is highly
flexible or undergoes large conformational change upon ligand binding.35, 40 To alleviate
the problem, Ligand Binder also supports fully explicit system representation with PBC and
comprehensive testing is underway. To enhance sampling and improve convergence, the
replica-exchange molecular dynamics (REMD) method is also adopted41, 42 and can be
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activated by the user. As high performance computing resources become increasingly
available, state-of-the-art free energy methodologies are expected to eventually migrate
toward the full replica-exchange FEP/MD simulations with PBC. Consequently, Ligand
Binder will support these trends by generating all the necessary input files for the highly
scalable simulation programs with built-in parallel/parallel features such as NAMD in the
future.
To test the efficacy of Ligand Binder, we have performed a set of illustrative absolute
binding free energy calculations for three non-polar aromatic ligands to the L99A mutant of
T4 lysozyme and three FK506-related ligands to FKBP12. Without any further modification
of the current protocol (i.e., generated input files), statistical errors within individual
calculations are found to be small (~1–2 kcal/mol), and the calculated binding free energies
generally agree well with the experimental measurements and the previous computational
studies. It is likely that statistical precision and convergence of the calculations could be
improved by carrying out multiple FEP/MD runs or by increasing the sampling times of all
the FEP windows. A larger statistical error is observed in FK506-related ligands. Thus,
slight modification based on the input files generated by Ligand Binder for better sampling
would be advisable for medium to large sized ligand molecules.
Ligand Binder allows one to quickly setup and perform FEP/MD simulations, thus providing
an ideal platform for accurate calculations of the absolute binding free energy. By providing
standardized input scripts containing sophisticated commands for various biasing potentials,
Ligand Binder could facilitate robust calculations of absolute binding free energy without
intimate knowledge of ligand molecule or lengthy trial simulations. Such an automated and
standardized protocol in alchemical free energy can also be used in evaluation of the binding
affinity of a large number of molecules or in a lead optimization process.
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Refer to Web version on PubMed Central for supplementary material.
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Illustration of translational and orientational restraints on SB3 ligand. Anchoring atoms are
represented as grey sphere. r (P1−L1), θ (∠P2P1L1), φ (∠P3P2P1L1) are defined for the
translational restraint, and α (∠P1L1L2), β (∠P2P1L1L2), and γ (∠P1L1L2L3) are defined
for the orientational restraint.
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Structures of ligand molecules used in this work. (A) Benzene, (B) Indole, (C) n-
butylbenzene, (D) 1,3-diphenyl-1-propyl-1-(3,3-dimethyl-1,2-dioxypentyl)-2-piperidine
carboxylate (SB3), (E) 1-cyclohexyl-3-diphenyl-1-propyl-1-(3,3-dimethyl-1,2-
dioxypentyl)-2-piperidine carboxylate (SBX), and (F) K506 (FK5). Symmetric groups
detected by Ligand Binder are colored in red.
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Reduced simulation systems for (A) SITE and (B) BULK using GSBP and SSBP boundary
potentials.
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Table 1
Important input and output files generated by Ligand Binder and during the FEP/MD simulations.
Filename Description
STEP1 Input step1_pdbreader.inp To read a protein-ligand complex structure
Output step1_pdbreader.pdb Structure after initialization in CHARMM
@lig/@lig.rtf Ligand topology file
@lig/@lig_g.rtf Ligand topology file (with atom groups)
@lig/@lig.prm Ligand parameter file
@lig/ndihe.str Symmetric groups found in the ligand if any
STEP2 Input step2.1_site_solvator.inp To solvate the binding site with a water sphere (SITE)
step2.2_bulk_solvator.inp To solvate the ligand with a water sphere (BULK)
Output step2.1_site_solvator.pdb Solvated simulation system for SITE
step2.2_bulk_solvator.pdb Solvated simulation system for BULK
STEP3 Input step3.1_gsbp_setup.inp To setup GSBP simulation system for SITE
step3.2_ssbp_setup.inp To setup SSBP simulation system for BULK
config.py Contains several (user-defined) configuration variables
step3_job.pbs Example PBS script for batch system
Output step3.1_gsbp_setup.pdb SITE simulation system after GSBP setup
step3.1_gsbp_setup.mij Calculated multipolar reaction field
step3.1_gsbp_setup.phix Calculated external reaction field
step3.2_ssbp_setup.pdb BULK simulation system after SSBP setup
STEP4 Input step4.1_site_gcmc.inp To adjust the number of water molecules in GSBP
step4.2_site_equil.inp To equilibrate SITE system
step4.3_restraint_setup.inp To setup anchoring atoms and restraint parameters
step4.3_restraint_geo.str To determine anchoring atoms
step4.3_restraint_geotest.str To test validity of anchoring atoms
step4.3_restraint_ref.str To determine the restraint parameters
step4.4_bulk_equil.inp To equilibrate BULK system
step4_job.pbs Example PBS script for batch system
Output step4.1_site_gcmc.crd SITE system after adjustment of number of water
step4.2_site_equil.dcd Trajectory of SITE system equilibration
step4.2_site_equil.crd Last snapshot of equilibrated SITE system
step4.3_restraint_geo.prm Anchoring atom definition
step4.3_restraint_geo.pdb Anchoring atoms (named as DUM)
step4.3_restraint_ref.prm Reference values for restraint potential
step4.3_restraint_consdihe.str Symmetric group restraints
step4.3_restraint_ligave.pdb Average structure of bound ligand during equilibration
step4.4_bulk_equil.pdb Last snapshot of equilibrated BULK system
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Filename Description
STEP5 Input step5.1_site_fes.inp FEP/MD input for SITE system (including PMF input)
step5.1_site_gconst.str To setup orientational/translational restraints
step5.2_bulk_fes.inp FEP/MD input for BULK system (including PMF input)
step5_jobmanager.com Script for submitting batch jobs
step5_template.pbs Example PBS script for batch system
STEP6 Input step6.1_wham_fep.inp WHAM input for FEP/MD simulations
step6.1_wham_fep.pbs Example PBS script for batch system
step6.2_wham_rmsd.inp WHAM input for PMF umbrella sampling simulations
step6.2_wham_rmsd.pbs Example PBS script for batch system
step6_wham.com Script for WHAM calculation
step6_table.py Example script to tabulate the binding free energy
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Table 5




This work§ Deng et. al.12 Wang et. al.14 Experiments36, 37
benzene −6.0 ± 0.3 −6.0 ± 0.2 - −5.2± 0.2
indole −2.5 ± 0.2 −4.2 ± 0.2 - −4.9± 0.1
n-butylbenzene −10.5 ± 0.5 −8.7 ± 0.4 - −6.7± 0.0
SB3 −13.1 ± 0.8 - −10.3 ± 0.4 −10.9± 0.1
SBX −10.4 ± 1.0 - −11.7 ± 1.0 −11.1± 0.2
FK5 −11.5 ± 1.0 - −10.1 ± 1.2 −12.7± 0.2
§
The free energies for this work are calculated by taking averages from the values in Table 4, and the errors are standard errors from the 3
independent calculations (C1, C2, and C3).
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Table 6
Comparison of free energy terms¶ with different selections of the anchoring atoms.
Ligand #§
benzene C1 −5.4 ± 0.3
C2 −5.3 ± 0.4
C3 −5.9 ± 0.2
indole C1 −9.0 ± 0.1
C2 −8.5 ± 0.1
C3 −8.8 ± 0.2
n-butylbenzene C1 −8.4 ± 0.2
C2 −9.5 ± 0.2
C3 −8.2 ± 0.3
SB3 C1 −24.0 ± 0.5
C2 −23.6 ± 1.4
C3 −25.7 ± 1.0
SBX C1 −22.7 ± 0.7
C2 −22.3 ± 0.8
C3 −23.0 ± 1.1
FK5 C1 −50.6 ± 0.8
C2 −49.2 ± 1.0
C3 −49.4 ± 1.5
¶
Units of free energies are kcal/mol. The errors of all the free energy values are standard deviation of the last five cycles of FEP/MD, each started
with the last snapshot of previous cycle and random velocities.
§
C1, C2, and C3 represent independent FEP/MD simulations for each ligand.
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